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ABSTRACT 
Cten (C-terminal tensin-like) is a member of the tensin protein family found in complex with 
integrins at focal adhesions. It promotes epithelial‐mesenchymal transition (EMT) and cell motility. 
The precise mechanisms regulating Cten are unknown, although we and others have shown that Cten 
could be under the regulation of several cytokines and growth factors. Since Transforming growth 
factor beta 1 (TGF-β1) regulates integrin function and promotes EMT / cell motility, we were 
prompted to investigate whether TGF-β1 induces EMT and cell motility through Cten signalling in 
colorectal cancer.  
TGF-β1 signalling was modulated by either stimulation with TGF-β1 or knockdown of TGF-
β1 in the CRC cell lines SW620 and HCT116. The effect of this modulation on expression of Cten, 
EMT markers and on cellular function was tested. The role of Cten as a direct mediator of TGF-β1 
signalling was investigated in a CRC cell line in which the Cten gene had been deleted (SW620ΔCten).  
When TGF-β1 was stimulated or inhibited, this resulted in, respectively, upregulation and 
downregulation of Cten expression and EMT markers (Snail, Rock, N-Cadherin, Src). Cell migration 
and cell invasion were significantly increased following TGF-β1 stimulation and lost by TGF-β1 
knockdown. TGF-β1 stimulation of the SW620ΔCten cell line resulted in selective loss of the effect of 
TGF-β1 signalling pathway on EMT and cell motility whilst the stimulatory effect on cell 
proliferation was retained.  
These data suggested Cten may play an essential role in mediating TGF-β1 induced EMT and 
cell motility and may therefore play a role in metastasis in CRC. 
 
Keywords: epithelial‐mesenchymal transition (EMT), colorectal cancer, transforming growth 
factor beta (TGF‐β), cell motility, cell invasion 
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INTRODUCTION 
C-terminal tensin-like (Cten, also known as tensin4) is a member of the tensin gene family 
which comprises four members (tensin1, tensin2, tensin3, and Cten/tensin4). This protein family 
localises to the cytoplasmic tails of integrins at focal adhesion sites. Cten shares high sequence 
homology to the C-terminus of the other tensins with a common Src homology 2 (SH2) domain and 
phosphotyrosine binding (PTB) domain. Unlike the other tensin protein members (tensins 1-3), Cten 
lacks the actin binding domain (ABD) which results in an inability to bind to the actin cytoskeleton 
and is thought to play a critical role in cellular processes such as cell motility 1. 
Cten is a putative biomarker in many cancers, acting as oncogene in most tumour types 
including the colon, breast, pancreas and melanoma, and it is particularly associated with metastatic 
disease 2. Cten expression is possibly upregulated through the activation of upstream signalling 
pathways since so far, no mutations or amplification of Cten in cancers have been documented. A 
study by Katz et al. showed that stimulation with EGF led to upregulated Cten expression at 
transcriptional level in breast cell lines, whereas others have shown that Cten is upregulated by the 
EGFR at post-transcriptional level 3,4. Further reports suggested that Cten is regulated by KRAS in 
both CRC and pancreatic cancer cells 5. Cten expression was also shown to be negatively regulated by 
STAT3 in CRC cell lines, whereas others have found that Cten is upregulated by STAT3 in human 
lung cancer cells 6,7. How Cten is activated and regulated in these tumours is unclear, nonetheless, 
multiple pathways seem to be involved, and it appears to be largely dependent on tissue type or 
context. 
 
Transforming growth factor beta 1 (TGF-β1) is a polypeptide member of the growth factor 
family that plays a physiological role in the regulation of wound healing, angiogenesis, 
differentiation, and proliferation. TGF-β 1 can function as a tumour suppressor in normal epithelial 
cells and in the early stage of cancer. However, the growth inhibitory function of TGF-β1 is 
selectively lost in late stage cancer which results in an induction of cell migration, invasion and 
metastasis 8,9. Previous studies have shown that TGF-β1 is involved in the regulation of EMT 
processes through numerous downstream pathways, including Ras/MAPK 10, RhoA 11, and Jagged 
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1/Notch 12. TGFβ1 has also been found to signal through FAK to upregulate EMT related 
mesenchymal and invasiveness markers and delocalise E-cadherin from the cell membrane 13. TGF-β1 
has been shown to regulate several integrins including αV, β1, and β3 in glioblastoma, fibroblast, and 
kidney epithelial cells 14. Others have suggested that the positive regulation of integrin αV, α6, β1, and 
β4 by TGF-β1 signalling is probably mediated via the activation of the TGF-β1/TGF-βRI/Smad2 
signalling pathway 15. Furthermore, the TGF-β1 mediated Smad signalling pathway has been shown 
to play an important role in EMT associated with metastatic progression 10. A study by Hung et al has 
also reported that TGF-β1 induces Cten up-regulation in a dose dependent manner and FGF2 mediates 
Cten-induced motility, however the role of Cten in TGF- β1-mediated EMT and motility was not 
explored 16. 
There are therefore several cellular functions and processes which are similarly regulated by 
Cten and TGF-β1. Both molecules seem to use FAK as a downstream messenger. However, a possible 
role of Cten in TGF-β1-mediated EMT and cell motility in CRC cells has not yet been postulated. 
Therefore, it was hypothesised that TGF-β may induce cell motility and promote EMT processes 
through the Cten signalling pathway.  
 
MATERIALS AND METHODS 
Cell Culture 
This work was performed in CRC cell lines HCT116 and SW620, which were a kind gift 
from Prof Ian Tomlinson. This work was also carried out in SW620ΔCten cell line which was 
previously established by our group 17. All cells were cultured in Dulbecco’s Modified Eagle’s 
Medium (DMEM) GlutaMAXTM supplement (Thermo Fisher Scientific, Carlsbad, CA) antibiotic free 
supplemented with 10% foetal bovine serum (FBS) (Sigma, St.Louis, MO) and maintained at 37°C in 
a 5% CO2 atmosphere. Cell line identities were authenticated by STR profiling.  
 
Cell Transfection  
Cells were transfected with small interfering RNA (siRNA) targeted to TGF-β1 (CCA CCU 
GCA AGA CUA UCG ACA UGG A) or luciferase (CGU ACG CGG AAU ACU UCG A) as a 
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negative control using Lipofectamine 2000 (Invitrogen, Paisley, UK) according to the manufacturer’s 
protocol. Cells were grown to 40-50% confluency and siRNA duplexes were added at a final 
concentration of 10 nM and 10 μl of Lipofectamine 2000 to each well of a 6-well plate. The cells were 
incubated with the transfection reagents for 6 hours and experiments performed 48 hours post 
transfection. 
 
Cell Treatment 
In order to stimulate TGFβ1 signalling, cells were seeded in a six well plate and starved in 
serum free DMEM for 24 hours at 37⁰C prior to stimulation. Cells at 50-60% confluency were treated 
with 0–20 ng/ml Recombinant Human TGFβ1 (R&D Systems, Minneapolis, MN) in DMEM growth 
media (supplemented with 10% FBS), with a total volume of 2 ml per well. After optimization in a 
time course from 24-96h, cells were harvested after incubation for 48 hours since this was considered 
the appropriate duration of TGFβ1 stimulation that caused expected changes in EMT markers. 
 
Western Blot 
Cell lysates were prepared using RIPA lysis buffer (Thermo Fisher Scientific, Carlsbad, CA) 
supplemented with phosphatase and protease inhibitor (Thermo Fisher Scientific, Carlsbad, CA). Fifty 
microgram of protein was added to NUPAGE LDS Sample Buffer (Thermo Fisher Scientific, 
Carlsbad, CA) containing 5% β-mercaptoethanol. The protein samples were heated to 90⁰C on a heat 
block for 5 minutes and cooled on ice for another 5 minutes. Following this, the protein samples were 
fractionated on a pre-cast 4–12% NUPAGE Bis-Tris-HCl buffered (pH 6.4) polyacrylamide gel 
(Thermo Fisher Scientific, Carlsbad, CA) using the NUPAGE gel electrophoresis system with 
NUPAGE MOPS SDS Running Buffer (Thermo Fisher Scientific, Carlsbad, CA) at 125 V for 90 
minutes. Proteins were then transferred onto PVDF membrane (GE Life Sciences) using the Trans 
Blot semi‐dry transfer system (Bio-rad laboratories, Hertfordshire, UK ). Following blocking in 5% 
milk or 5% BSA in 0.1% tween PBS or 0.1% tween TBS (dependent on antibody diluents), 
membranes were incubated with optimally diluted primary antibodies overnight at 4°C 
(supplementary Table 1). Following washing, membranes were incubated with the appropriate 
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anti‐mouse or anti‐rabbit secondary antibody for 1 h at room temperature (supplementary Table 1). 
The ECL prime detection kit (GE Life Sciences) was used for protein band visualisation using the 
C‐DiGiT Blot Scanner (LI‐COR, Lincoln, NE). Densitometric analysis of the bands was performed 
using ImageJ software. Pixel counts for each protein of interest were normalized to β‐actin.  
 
Cell Viability Assay  
PrestoBlue Cell Viability Reagent (Thermo Fisher Scientific, Carlsbad, CA) was used as an 
indirect method to measure the total number of live cells. Briefly, 5 x 103 cells were seeded in a 96 
well plate and allowed to attach for 24 hours. Following this, 100 μl of PrestoBlue Cell Viability 
Reagent was added to the cells and without cells as control, and incubated for 1 hour at 37⁰C. 
Following incubation, the relative fluorescent units of each well of the 96 well plate were then 
measured using the BMG FLUOstar Optima Plate reader (540 nm excitation/ 590 nm emission). 
Further readings were taken at 48 and 72-hour time points. The blank fluorescence reading was 
subtracted from each experimental fluorescence reading and the blank corrected values were then 
normalised to the 24 hour time point. 
 
Transwell Migration and Invasion Assays 
The changes in cell migration were assessed in 24 well plates using the Transwell system 
(Corning, NY). Cells were treated with mitomycin C (10 µg/ml) for 3 hours and washed 3 times with 
PBS to inhibit cell proliferation. The Transwell inserts (6.5 mm diameter; 8 μm pore size) were 
incubated in DMEM at 37°C for 1 hour prior to use. Following this, 600 μl of DMEM (20% FBS) was 
added to the outer wells of the Transwell plate and the Transwell inserts placed inside. A total of 
1 × 105 cells in DMEM (10% FBS) were seeded onto the Transwell insert. The plate was incubated at 
37°C for 24 hours. Following this, the cells that had migrated through to the bottom of the outside 
well, using the higher FBS concentration as a chemoattractant, were manually counted. Triplicate 
wells were seeded for each experimental condition. The Transwell invasion assay was performed 
according to this protocol with the exception that 2 × 105 cells were seeded onto a Transwell insert 
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coated in matrigel reduced growth factor  at 0.3 mg/ml (Corning, NY) and cells allowed to migrate for 
48 hours prior to counting. 
 
Wound Healing  
Wound healing scratch assay was performed as an alternative assay to assess cell migration. 
Briefly, 5-7 x 105 cells /ml were seeded into culture-insert 2 well (Ibidi, Martinsried, Germany) 
attached in 6 well plates and incubated for 24 hours at 37°C until they reached confluency. After cell 
attachment, the culture inserts were removed, and the cells were treated with mitomycin C (Sigma, St. 
Louis, MO) at 10 µg/ml for 3 hours to inhibit proliferation and remove any influence different 
proliferation rates could have in the apparent migration of TGFß-treated cells. Cells were then 
cultured under normal conditions, and the pictures were taken at 0, 24, or 48 hours using an inverted 
microscope (Nikon, Surrey, UK) at 10x magnification. The width of the cell free gap was 
approximately 500 microns (+/- 50 microns) at time 0 hours. Experiments were performed in 
duplicate and on at least on two separate occasions. Cell migration was assessed by measuring the 
remaining open area of the wound by ImageJ software. 
 
Statistical Analysis  
Results were tested for a normal distribution, and the unpaired t‐test or analysis of variance 
(ANOVA) statistical tests were applied using GraphPad Prism (version 6). For both ANOVA and 
unpaired t-test a two-tailed value of P<0.05 was deemed to have statistical significance. 
 
RESULTS 
TGF-β1 Regulates Cten Expression 
Both TGF-β1 and Cten induce EMT and cell motility and are associated with integrin 
signalling. Thus it was of interest to determine whether Cten expression is under the regulation of the 
TGF-β1 signalling pathway in CRC cells. After a timecourse experiment lasting up to 96h, a 48h 
endpoint was selected for stimulation with TGF-β1 as this was sufficient to produce expected changes 
in EMT markers (data not shown). SW620 cells were then treated with different concentrations of 
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TGF-β1-human recombinant protein from 0 to 20 ng/ml for 48 hours and the changes in protein level 
of Cten and its downstream targets, ROCK1, N-cadherin, E-cadherin, Src, and Snail were evaluated 
by western blot. SW620 cells showed a dose-dependent increase in Cten, ROCK1, Src, Snail, and N-
cadherin expression, whereas the protein expression level of E-cadherin was decreased following 
stimulation with TGF-β1 (Figure 1 A). The optimum concentration of TGF-β1-human recombinant 
protein (20 ng/ml) was selected for subsequent TGF-β1 stimulation experiments. In SW620, cell 
migration, invasion, and proliferation were increased when cells were treated with TGF-β1-human 
recombinant protein compared to untreated control (Figure 1B,C,D,E). 
 
The relationship between TGF-β1 and Cten was further investigated in an additional cell line, 
HCT116. In agreement with the findings in SW620 cells, stimulation of TGF-β1 was associated with 
an increase in the protein expression levels of Cten, ROCK1, Src, Snail, and N-cadherin, whereas E-
cadherin expression was inhibited (Figure 2A). The ability of TGF-β1 to alter cell motility and 
viability was then investigated using the Transwell migration assay, wound healing assay, Transwell 
Matrigel invasion assay, and cell viability assay. In HCT116 cell lines, cell migration, invasion, and 
proliferation were increased when cells were treated with TGF-β1-human recombinant protein 
compared to untreated control (Figure 2B,C,D,E).  
 
The effect of TGF-β1 on Cten and its downstream targets was again investigated in SW620 
cell but using an alternative methodology. Assuming that there was some endogenous production of 
TGF-β1 by the cell lines, this was transiently knocked down by siRNA and changes in protein 
expression level of Cten, ROCK1, Src, Snail, E-cadherin and N-cadherin were evaluated by western 
blot. Confirming the TGF-β1 stimulation results, knockdown of TGF-β1 resulted in a reduction of 
Cten, ROCK1, Src, Snail, N-cadherin protein expression levels. Additionally, TGF-β1 knock down 
was associated with an increase in the expression level of E-cadherin compared to luciferase targeting 
siRNA control (Figure 3 A). The effect of TGF-β1 knockdown on cell functions was also tested in 
this study (Figure 3B,C,D,E). Knockdown of TGF-β1 was associated with a significant decrease in 
cell migration, invasion and proliferation compared to the luciferase control (Figure 3B,C,D,E). 
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Collectively, these findings suggest that TGF-β1 may promote both cell motility and proliferation 
through the upregulation of EMT processes in CRC cells. 
 
Cten deletion selectively abrogates TGF-β1 Induced Cell Migration and Invasion.  
 
Our data have shown that TGFβ1 is a positive regulator of Cten expression and a number of 
markers of EMT. We also showed that TGFβ1 signalling induces cell motility (both migration and 
invasion). Since Cten induces EMT and cell motility, it is reasonable to hypothesise that Cten is a 
direct mediator of TGFβ1 activity. We have previously described the creation of SW620ΔCten 17. This 
is derivative of SW620 in which Cten has been deleted using CRISPR/Cas9 technology. In order to 
test our hypothesis, SW620ΔCten was stimulated with TGFβ1 and Western blotting was performed. The 
results revealed that stimulation with TGF-β1 was associated with a small increase in N-cadherin 
expression but ROCK1, Src, Snail, and E-cadherin protein expression level remained unchanged 
compared to the sham-treated cells control (Figure 4 A). This implies that Cten may be responsible for 
TGF-β1 induced EMT. A direct comparison of SW620 and SW620 ΔCten protein levels of ROCK1, N-
cadherin and Snail upon TGF-β1 stimulation at concentrations ranging 5-20ng/mL is provided on 
Figure S1. 
To determine if Cten was functionally relevant to TGF-β1 mediated activity, SW620ΔCten was 
stimulated by TGF-β1 and assays for Transwell migration, wound healing, Matrigel invasion, and cell 
viability were performed. (Figure 4B,C,D,E). The deletion of Cten in SW620ΔCten cells resulted in an 
abrogation of the ability of TGF-β1 to induce cell migration or invasion whilst the ability to induce 
cell proliferation was retained. Thus Cten appears not to be involved in TGF-β1 induced cell 
proliferation, but it may be a signalling intermediate in the TGF-β1/EMT pathway regulating cell 
migration and invasion in CRC cells.  
 
DISCUSSION 
EMT is a critical process occurring during tumour metastasis. During the EMT process, 
epithelial cells show loss of cell to cell adhesion by E-cadherin downregulation at adherens junctions, 
 10 
 
cytoskeleton reorganisation via switching from keratin to vimentin intermediate filaments, loss of 
apical-basal polarity, acquisition of mesenchymal cell phenotype and increased cell invasion and 
migration 18. Cten has been shown to act as oncogene in most tumour types and involved in regulation 
of EMT processes, however, the mechanisms that upregulate the expression of Cten induced EMT 
have not been elucidated 17, 19-21. Research from our laboratory has suggested that Cten expression is 
regulated by EGFR/KRAS signalling in pancreatic and colorectal cancer cell lines 5 validating a 
previous study by Katz et al 3 showing the role of Her2 in up-regulating Cten in breast cancer cell 
lines. Furthermore, we and others have also found that Cten could be under the regulation of several 
cytokines such as IL6/Stat3 6 and growth factors, including EGF, NGF and FGF2 which also induces 
cell motility 16. The present study directly shows, for the first time an essential role for Cten in TGF-
β1-induced EMT and cell motility in CRC cells and that this may be through upregulation of the 
Src/ROCK1/Snail signalling pathway.  
TGF-β1 reputedly plays a key role in promoting EMT initiation and tumour metastasis. In the 
latest classification of CRCs 22, the most aggressive class (CMS4) is characterised by TGF-β 
activation. It has been documented that TGF-β1 induces the expression of several transcription factors 
including Twist, Zeb, Slug, and Snail 23. Here, using different methods of modulating TGF-β1 
activity, we have shown that TGF-β1 is a positive regulator of Cten expression. We have also shown 
that TGF-β1 is a positive regulator of Src, ROCK, and Snail expression. Since these are putative 
targets of Cten, it begs the question whether, in this case, they are directly up-regulated by TGF-β1 
signalling or whether they are up-regulated by Cten as a secondary event. Using the SW620ΔCten cell 
line (in which Cten is deleted) we were able to conclusively show that up-regulation of these 
molecules is Cten-dependent. The mechanisms by which these proteins are up-regulated are uncertain 
although we have previously shown that Cten causes post-translational stabilisation of Snail17. The 
link between TGF-β1 and Cten may be through integrins since TGF-β1 induces integrin activation 
and Cten is found in complex with the cytoplasmic tail of integrins. However there are also several 
other downstream targets of TGF-β1 mediated EMT which may possibly be involved in regulation of 
Cten and further investigation of markers/signalling pathways such as Ras/MAPK 10, RhoA 11, and 
Jagged 1/Notch 12 is warranted.  
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Our data suggest a novel downstream signalling pathway for TGF-β1 which is mediated 
through Cten. In order to ascertain whether this represented a functionally relevant pathway, we 
performed assays to assess motility (both by invasion and migration assays) and cell proliferation. In 
our models, TGF-β1 signalling was shown to increase cell proliferation, migration (both transwell 
migration and wound healing) and cell invasion. These data are in accordance with previous studies 
that TGF-β1 induced EMT can promote cell motility and proliferation in a vast range of different 
tumour cells such as breast cancer and oral squamous cell carcinoma 24,25. Intuitively one would think 
that the induction of cell motility was mediated through the Cten pathway. This was confirmed by our 
observation that there was a selective loss of the effect of TGF-β1 treatment on both cell migration 
and invasion in the SW620ΔCten cell line while the effect of TGF-β1 treatment on cell proliferation was 
unaffected. This is completely in line with our previous data showing that Cten regulates cell motility 
and does not affect cell proliferation18.  
It is not unexpected that TGF-β1 will activate different signalling pathways to regulate 
different cellular functions. Our data show that the Cten pathway is an important factor in the TGF-β1 
regulation of cell motility and they may explain other observations that have been made. Thus 
previous published data from our group have shown that Cten induces EMT and promotes cell 
motility through FAK, ILK and Snail signalling 16,20,26. Previously, it has been shown that FAK and/or 
ILK are required for TGF-β1 induced EMT and to promote cell motility 13,27. Snail also has been 
shown to act as a mediator of TGF-β1 induced EMT28. We would now hypothesise that Cten is one of 
the missing links which would explain FAK/ILK/Snail dependence of TGF-β1 induced cell motility. 
In addition to Cten, there are other downstream pathways involved in TGF-β1 mediated cell 
migration, including JAK/STAT3 29, PI3K-Akt 30, and Reelin 31, so it would be of interest to 
determine whether Cten acts in parallel or synergistically with these pathways in future studies. 
In summary, the data presented have indicated that TGFβ1 and Cten signalling may cooperate 
in promoting EMT and cell motility. Regulation of downstream markers of EMT such as 
Src/ROCK1/Snail by TGFβ1 is dependent on Cten. These processes are relevant to the development 
of metastasis and our data open up the possibility of targeting Cten in CRC.   
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Figure legends 1 
Figure 1: TGFβ1 increases Cten protein expression in a dose-dependent manner. A) SW620 cells 2 
were stimulated with TGFβ1-human recombinant protein (R&D systems), (0-20 ng/ml) for 48 hours and 3 
the changes in Cten, ROCK1, N-cadherin, E-cadherin, Src, and Snail protein expression were determined 4 
by western blot (upper panel). Graph on the lower panel represents the densitometry values calculated for 5 
each protein band normalised to actin, representative of 3 experiment replicates. Stimulation of SW620 6 
cells with TGFβ1 treatment (20 ng/ml for 48 hours) induced closure of wound compared to untreated 7 
control (P = 0.0024). C) Stimulation of TGFβ1 was associated with an increase in cell migration 8 
compared to untreated SW620 cells control (P = 0.0005). D) Treatment of SW620 cells with TGF-β1-9 
human recombinant protein enhanced cell invasion compared to untreated control (P = 0.0055). E) 10 
Stimulation of TGFβ1 in SW620 cells was associated with an increase in cell proliferation compared to 11 
untreated control (P ≤ 0.0001). Results are representative of at least 3 experimental replicates. *** 12 
indicates P<0.001 and ** indicates P<0.01 13 
 14 
Figure 2: TGFβ1 stimulation increases Cten protein expression in HCT116 cells. A) HCT116 15 
cells were pre-treated with TGF-β1-human recombinant protein (20 ng/ml for 48 hours) and the changes 16 
in Cten, ROCK1, N-cadherin, E-cadherin, Src, and Snail protein expression were determined by western 17 
blot (upper panel). Graph on the lower panel represents the densitometry values calculated for each 18 
protein band normalised to actin, representative of 3 experimental replicates. B) Treatment of HCT116 19 
cells with TGF-β1-human recombinant protein (20 ng/ml for 48 hours) induced wound closure compared 20 
to untreated control (P = 0.0084). C) Stimulation of TGFβ1 was associated with an increase in cell 21 
migration compared to untreated HCT116 cells control (P = 0.0032). D) Stimulation of SW620 cells with 22 
TGFβ1 treatment increased cell invasion compared to untreated control (P = 0.0022). E) Stimulation of 23 
TGFβ1 in HCT116 cells resulted in an increase in cell proliferation compared to untreated control (P ≤ 24 
0.0001). Results are representative of at least 3 experimental replicates. *=P<0.05, **=P<0.01, 25 
***=P<0.001. 26 
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 27 
Figure 3:  TGFβ1 knockdown decreases Cten protein expression in SW620 cells. A) SW620 28 
cells were transfected with TGFβ1 targeting siRNA duplexes (200 nM/ml for 48 hours) and the changes 29 
in Cten, ROCK1, N-cadherin, E-cadherin, Src, and Snail protein expression were determined by western 30 
blot (upper panel). Graph on the lower panel represents the densitometry values calculated for each 31 
protein band normalised to actin, representative of 3 experiment replicates. B) Knockdown of TGFβ1 in 32 
SW620 decreased wound closure compared to luciferase targeting siRNA control (P = 0.0016). C) 33 
Knockdown of TGFβ1 was associated with a decrease in cell migration compared to luciferase transfected 34 
HCT116 cells control (P = 0.0003). D) Knockdown of TGFβ1 in SW620 cells decreased cell invasion 35 
compared to luciferase siRNA control (P = 0.0005). E) Knockdown of TGFβ1 in SW620 cells resulted in 36 
a reduction in cell proliferation compared to luciferase siRNA control (P ≤ 0.0001). Results are 37 
representative of at least 3 experimental replicates. *=P<0.05, **=P<0.01, ***=P<0.001 38 
 39 
Figure 4: TGFβ1 signals through Cten to regulate EMT and promotes cell migration and 40 
invasion. A) Stimulation of SW620ΔCten cells with TGFβ1 treatment (20 ng/ml for 48 hours) was 41 
associated with a small increase in N-cadherin expression and ROCK1, Src, Snail, and E-cadherin protein 42 
expression level remained unchanged from the untreated cells control (upper panel). Graph on the lower 43 
panel represents the densitometry values calculated for each protein band normalised to actin. B) Wound 44 
healing assay showed no significant differences between TGFβ1 stimulation and untreated SW620ΔCten 45 
cells control (P = 0.0585). C) Stimulation of TGFβ1 in SW620ΔCten cells did not cause a significant 46 
increase in cell migration compared to untreated control (P = 0.1561). D) Treatment of SW620ΔCten cells 47 
with TGF-β1-human recombinant protein did not enhance cell invasion compared to untreated control (P 48 
= 0.1469). E) Stimulation of TGFβ1 in SW620ΔCten cells was associated with an increase in cell 49 
proliferation compared to untreated control (P ≤ 0.0001). Results are representative of at least 3 50 
experimental replicates. *=P<0.05 51 
 52 
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Figure 5 - TGFβ1 stimulation causes upregulation of Cten and its downstream targets (Src, Rock1, Snail) 53 
and also N-cadherin, conversely there is downregulation of E-cadherin which is characteristic of EMT. 54 
These changes in EMT biomarkers are coherent with increases in Cten-dependent cell motility and 55 
invasion. The effect TGFβ1 stimulation has on cell proliferation is independent of Cten signalling, as 56 
observed by using SW620ΔCten (Figure 4E). 57 
 58 
Figure S1 – Optimization of TGFβ1 stimulation in a range of concentrations (5-20ng/mL) during 48h and 59 
alterations in ROCK1, N-cadherin, Cten and Snail protein expression determined by western blot using 60 
the cell lines SW620 and its isogenic derivative where Cten was deleted by CRISPR/Cas9 technology 61 
(SW620ΔCten).  62 
 63 
64 
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67 
Supplementary table 1: Optimised antibody conditions for western blot 
Antibody Source Supplier Primary 
dilution 
Secondary 
dilution 
Diluent 
ROCK1 Rabbit Cell signalling 1:1,000 1:1,000  5% BSA+0.1% Tween TBS 
N-Cadherin Mouse Abcam 1:500 1:5,000  5% BSA+0.1% Tween TBS 
E-Cadherin Rabbit Cell signalling 1:1,000 1:5,000  5% BSA+0.1% Tween TBS 
Cten Mouse Sigma 1:5,000 1:1,000 5% Milk+0.1% Tween PBS 
Tubulin Mouse Abcam 1:5000 1:2000 5% Milk+0.1% Tween TBS 
Lamin B1 Rabbit Abcam 1:10,000 1:5000 5% BSA+0.1% Tween TBS 
Src Rabbit Cell signalling 1:5,000 1:1,000 5% BSA+0.1% Tween PBS 
TGFβ1 Rabbit Cell signalling 1:5,000 1:1,000 5% BSA+0.1% Tween TBS 
Actin Mouse Sigma 1:20,000 1:10,000  5% Milk+0.1% Tween PBS 
Snail Rabbit Cell signalling 1:1,000 1:5,000 5% BSA+0.1% Tween PBS 
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